Patents by Inventor Mia Akerfeldt

Mia Akerfeldt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-cancer compounds
    Patent number: 10745355
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: August 18, 2020
    Assignee: THE UNIVERSITY OF SYDNEY
    Inventors: Lenka Munoz, Fadi Maged Shokry Gurgis, Mia Akerfeldt, Michael Kassiou
  • ANTI-CANCER COMPOUNDS
    Publication number: 20180273478
    Abstract: The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
    Type: Application
    Filed: January 29, 2016
    Publication date: September 27, 2018
    Applicant: THE UNIVERSITY OF SYDNEY
    Inventors: Lenka Munoz, Fadi Maged Shokry Gurgis, Mia Akerfeldt, Michael Kassiou
  • TREATMENT OF ABNORMALITIES OF GLUCOSE METABOLISM WITH AN ANTAGONIST OF INHIBITOR OF DIFFERENTIATION 1
    Publication number: 20130171158
    Abstract: A method of treating or preventing an abnormality of glucose metabolism in a subject, the method comprising administering an antagonist of Inhibitor of Differentiation 1 (Id1) to the subject.
    Type: Application
    Filed: June 29, 2011
    Publication date: July 4, 2013
    Applicant: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Mia Akerfeldt, Ross Laybutt